Clinical trial
Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation
NCT02675374 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 5, 2016
- Completion date
- July 18, 2017
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemodynamic instability, vasoplegic syndrome